STOCK MARKET Biocon shares jump over 3% after US FDA nod for diabetes drug Dapagliflozin tablets Apr 8, 2026
Biocon share price jumps 4% after its subsidiary receives multiple market access agreements for Yesintek May 5, 2025
Biocon Pharma secures US FDA approvals for Lenalidomide, Dasatinib, and Rivaroxaban tablets Mar 4, 2025
Biocon shares up nearly 3% as Q3 results highlight EBITDA growth of 16% and revenue rise of 7% Jan 31, 2025
Top Q3 FY25 Results Today on January 30, 2025: Adani Enterprises, Adani Ports, Bajaj Finserv, BEL, Biocon, Dabur, Prestige Estates Jan 30, 2025